World Library  
Flag as Inappropriate
Email this Article

Aldose reductase inhibitor

Article Id: WHEBN0000056350
Reproduction Date:

Title: Aldose reductase inhibitor  
Author: World Heritage Encyclopedia
Language: English
Subject: COMT inhibitor, Matrix metalloproteinase inhibitor, Thymidylate synthase inhibitor, Oudenone, Ribonucleotide reductase inhibitor
Collection: Aldose Reductase Inhibitors
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Aldose reductase inhibitor

Aldose reductase inhibitors are a class of drugs being studied as a way to prevent eye and nerve damage in people with diabetes.

Contents

  • Mechanism 1
  • Examples 2
  • Diabetic cataract 3
  • Asthma and COPD 4
  • References 5

Mechanism

Their target, aldose reductase, is an enzyme that is normally present in many other parts of the body, and catalyzes one of the steps in the sorbitol(polyol) pathway that is responsible for fructose formation from glucose. Aldose reductase activity increases as the glucose concentration rises in diabetes in those tissues that are not insulin sensitive, which include the lenses, peripheral nerves and glomerulus. Sorbitol does not diffuse through cell membranes easily and therefore accumulates, causing osmotic damage which leads to retinopathy and neuropathy.

Examples

Examples of aldose reductase inhibitors include:

Natural sources reported to inhibit aldose reductase include indian gooseberry, spinach, cumin seeds, fennel seeds, basil leaves, lemon, black pepper, orange, curry leaves, cinnamon [2] and lichen.[3]

Diabetic cataract

Diabetic cataract formation follows an increase in sugars in the lens. The excess sugar within the lens is reduced by aldose reductase to its alcohol, but the lens capsule is relatively impermeable to sugar alcohols. Because of the excess sugar alcohol (polyol), the lens imbibes water, causing osmotic imbalance. Eventually, increased sodium and decreased potassium levels and decreased glutathione levels lead to cataract formation. Topical administration of aldose reductase inhibitors have been shown to prevent the cataract in rats.[4]

Asthma and COPD

This class of drugs is also under investigation as a possible root pathology modulating treatment for asthma and COPD since it has been shown[5] that they inhibit goblet cell metaplasia in the respiratory epithelium, thereby reducing the copious mucous secretion associated with these.

References

  1. ^ Várkonyi T, Kempler P (2007). "Diabetic neuropathy: new strategies for treatment".  
  2. ^ Saraswat, M.; Muthenna, P.; Suryanarayana, P.; Petrash, J. M.; Reddy, G. B. (2008). "Dietary sources of aldose reductase inhibitors: Prospects for alleviating diabetic complications". Asia Pacific journal of clinical nutrition 17 (4): 558–565.  
  3. ^ Raj, P. S.; Prathapan, A; Sebastian, J; Antony, A. K.; Riya, M. P.; Rani, M. R.; Biju, H; Priya, S; Raghu, K. G. (2014). "Parmotrema tinctorum exhibits antioxidant, antiglycation and inhibitory activities against aldose reductase and carbohydrate digestive enzymes: An in vitro study". Natural Product Research 28 (18): 1480–4.  
  4. ^ Newell, FW. Ophthalmology: Principles and Concepts, Fifth Edition. London: The CV Mosby Company, 1982, p. 332.
  5. ^ University of Texas Medical Branch at Galveston (2011, January 27). Discovery could lead to new therapies for asthma, COPD. ScienceDaily. Retrieved January 27, 2011, from http://www.sciencedaily.com­ /releases/2011/01/110127101325.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily+%28ScienceDaily%3A+Latest+Science+News%29&utm_content=Google+Reader


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.